Executive and concierge health clinics are redefining prevention by offering comprehensive, personalized programs. Whole-body MRI, genomic testing, and lifestyle assessments provide valuable information but many clinics are now looking to add real-time biological signals that reflect what’s happening in the body today.
The miRoncol Real-time Multi-Cancer Early Risk Assessment offers exactly that: a simple blood-based test that integrates seamlessly into your clinic’s preventive health packages.
Add molecular cancer risk testing alongside imaging, blood panels, and lifestyle reviews.
Track evolving biological risk as part of age- and health-span monitoring.
Offer peace of mind to clients who prioritize prevention, clarity, and confidence in health decisions.
This is an early risk assessment tool, not diagnostic. Results should always be interpreted in collaboration with physicians and alongside conventional screenings.
By incorporating miRoncol’s Real-time Multi-Cancer Early Risk Assessment, executive clinics can deliver a new dimension of prevention giving clients clarity today, and confidence in their future.